Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
Clinical trial NCT00840671 · COMPLETED
Trial details
- NCT number
- NCT00840671
- Sponsor
- Ever Neuro Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2008-03-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.